Search results for "Affect"

showing 10 items of 1382 documents

Psychotropic drugs and driving: prevalence and types

2013

Background Some psychotropic medications (e.g., benzodiazepines, sedative antidepressants, etc.) may impair cognitive and psychomotor functions and, therefore, endanger traffic safety (Ravera, Br J Clin Pharmacol, 72(3):505–513, 2011). They affect detection, registration, and information processing, problem solving, and decision-making processes, and they also affect emotional and social aspects. The objective of this research was to clarify three closely related issues that are significant for traffic safety: the prevalence of psychotropic drugs on driving, the most frequently used psychotropic drugs to treat depression, anxiety, insomnia, or any tranquilizers (whether it is a medical pres…

Psychomotor learningPublic healthmedicine.medical_specialtyPsychotropic drugsDriversEpidemiologybusiness.industryPoison controlAffect (psychology)MedicinesPsychiatry and Mental healthInjury preventionRoad safetyMedicineAnxietyPsychopharmacologyMedical prescriptionmedicine.symptomPrimary ResearchbusinessPsychiatryPsychotropic AgentAnnals of General Psychiatry
researchProduct

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

2009

Both agonists (e.g. Delta(9)-tetrahydrocannabinol, nabilone) and antagonists (e.g. rimonabant, taranabant) of the cannabinoid type-1 (CB(1)) receptor have been explored as therapeutic agents in diverse fields of medicine such as pain management and obesity with associated metabolic dysregulation, respectively. CB(1) receptors are widely distributed in the central nervous system and are involved in the modulation of emotion, stress and habituation responses, behaviours that are thought to be dysregulated in human psychiatric disorders. Accordingly, CB(1) receptor activation may, in some cases, precipitate episodes of psychosis and panic, while its inhibition may lead to behaviours reminiscen…

PsychosisCannabinoid receptorEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPharmacologyEndocrinologyTaranabantPiperidinesReceptor Cannabinoid CB1RimonabantCannabinoid Receptor ModulatorsmedicineAnimalsHumansDronabinolDepressive Disorderbusiness.industryCannabinoid Receptor Agonistsmedicine.diseaseAnxiety DisordersEndocannabinoid systemNabiloneAffectPyrazolesCannabinoidRimonabantbusinessNeurosciencemedicine.drugBest Practice & Research Clinical Endocrinology & Metabolism
researchProduct

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI s…

2021

Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid adjustment with symptom dimensions in a large first episode psychosis (FEP) sample. We used data from the international EU-GEI study. Bifactor modelling of the Operational Criteria in Studies of Psychotic Illness (OPCRIT) ratings provided general and specific symptom dimension scores. Premorbid Adjustment Scale estimated premorbid social (PSF) and academic adjustment (PAF), and WAIS-brief version measured IQ. A MANCOVA model examined the relationship between symptom di…

PsychosisFirst episode psychosiscognitive domainsPremorbid Adjustment ScaleQUOCIENTE DE INTELIGÊNCIATransdiagnostic Premorbid adjustmentNEGATIVE SYMPTOMSArticlesymptom dimensionspremorbid adjustmentWORKING-MEMORYSecondary analysisFirst episode psychosisfirst episode psychosis1ST-EPISODE NONAFFECTIVE PSYCHOSISMedicineScopusCognitive domain[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Settore MED/25 - PsichiatriaBiological PsychiatryTransdiagnosticbusiness.industryWorking memoryConfoundingCognitive domainsCognitionBIPOLAR DISORDERSymptom dimensionsmedicine.diseaseGENE-ENVIRONMENT INTERACTIONSFirst episode psychosiCANNABIS USEPsychiatry and Mental healthSymptom dimensionPerceptual reasoningJCRIQSOCIAL COGNITIONtransdiagnosticPROCESSING-SPEEDNEURODEVELOPMENTAL TRAJECTORIES[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Premorbid adjustmentbusinessSCHIZOAFFECTIVE DISORDERClinical psychology
researchProduct

Psychosis, symbol, affectivity 2: another perspective on the treatment of psychotic disorder

2021

This is the second of two papers concerning our study into an integrated approach to psychotic disorders conducted at the University Psychiatry Unit of Palermo's Polyclinic over approximately 15 years; this paper concentrates on the clinical phenomena. The study aimed to find the best possible treatment and to improve the prognosis of this patient group. We have explored the efficacy of a range of psycho-therapeutic (cognitive-behavioural, systemic-relational, psychodynamic, group and others), psycho-pharmaceutical, psychiatric rehabilitative and psycho-educational treatments, with a hermeneutic approach instead of a systematic one. The study's conclusions, described in the paper, are that …

PsychosisPsychotherapistJungian Theorymedia_common.quotation_subjectEmotionsaffective neuroscience analytical psychology C.G. Jung J.W. Perry psychotic onset treatment of psychosesPerspective (graphical)medicine.diseasePsychodynamicsPsychicClinical PsychologySymbolPolyclinicPsychotic DisordersSettore M-PSI/08 - Psicologia ClinicamedicineHumansMeaning (existential)Patient groupPsychologymedia_commonJournal of Analytical Psychology
researchProduct

Manipulating feedback on schizophrenia: Evidence from a Posner task.

2021

Abstract Individuals with schizophrenia show difficulties in achieving vital objectives. Abnormal behavioral and emotional responses to environmental feedback may be some of the psychological mechanisms underlying this lack of goal attainment in schizophrenia. The present study aims to assess how different types of feedback may affect performance in a computerized affective Posner task (non-monetary vs. monetary rewards; contingent vs. non-contingent feedback). The sample was composed of 32 patients with schizophrenia and 35 controls. Reaction times and error rates were the behavioral measurements. The emotional experience was assessed through self-reported affective scales. The results ind…

PsychosisSchizophrenia (object-oriented programming)media_common.quotation_subjectFrustrationAffect (psychology)medicine.diseaseTask (project management)ArousalFeedbackPsychiatry and Mental healthFeelingRewardmedicineReaction TimeSchizophreniaHumansIn patientAttentionPsychologyBiological PsychiatryCognitive psychologymedia_commonJournal of psychiatric research
researchProduct

Does market concentration affect prices in the urban water industry?

2015

This paper analyzes the relationship between market concentration in the private segment of the water industry and water prices with a sample of municipalities located in the Southern Spanish region of Andalusia. In doing so, several Heckman sample selection models are estimated with the main finding being that market concentration increases the price of water for residential use charged by private companies. The main policy recommendation is that urban water service privatization must be accompanied by the appropriate regulatory and institutional frameworks to promote competition among businesses and monitor water pricing.

Public AdministrationNatural resource economicsmedia_common.quotation_subjectGeography Planning and DevelopmentControl de preusSample (statistics)Water industryManagement Monitoring Policy and LawEnvironmental Science (miscellaneous)Affect (psychology)Urban policyCompetition (economics)Concentració industrialEconomicsIndustrymedia_commonPrice controlbusiness.industryIndustrial concentrationPolítica urbanaWaterWater pricingMarket concentrationIndústriaPrivatizationAiguaCommerceService (economics)Urban waterbusinessPrivatització
researchProduct

Ageing and COPD affect different domains of nutritional status: the ECCE study

2010

Chronic obstructive pulmonary disease (COPD) and ageing may contribute to malnutrition. We aimed to explore whether COPD and ageing determine malnutrition in different manners. 460 stable COPD outpatients (376 males and 84 females) from the Extrapulmonary Consequences of COPD in the Elderly (ECCE) study database were investigated (age 75.0±5.9 yrs; forced expiratory volume in 1 s 54.7±18.3% predicted). Nutritional status was evaluated using the Mini Nutritional Assessment® (MNA) questionnaire. From the MNA, three scores exploring the domains of the nutritional status were calculated: body composition, energy intake and body functionality scores. Global Initiative for Chronic Obstructive Lun…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyAgingmedia_common.quotation_subjectAppetiteNutritional StatusSettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Pulmonary Disease Chronic ObstructiveInternal medicineSurveys and QuestionnairesActivities of Daily LivingmedicineHumansGeriatric Assessmentmedia_commonAgedCOPD Ageing nutritionGeriatricsAged 80 and overCOPDbusiness.industryMalnutritionAppetiteNutritional statusmedicine.diseaseNutrition SurveysObstructive lung diseaseMalnutritionAgeingPhysical therapyBody CompositionFemalebusinessEnergy Intake
researchProduct

An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

2016

Asthma in the elderly (>65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment. There are a variety of factors related to aging itself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular composition and function in asthmatic airways. These processes and differences from younger individuals with asthma are not well u…

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyAgingImmunosenescenceaging; immunosenescence; lung function; phenotype; reactive airways diseaseDiseaseComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Diagnosis Differential03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineimmune system diseasesreactive airways diseasemedicineHumans030212 general & internal medicineDisease management (health)LungSocieties MedicalAsthmaAgedAmerican Thoracic Society DocumentsLungbusiness.industryDisease Managementlung functionImmunosenescencemedicine.diseaseComorbidityAsthmaUnited Statesrespiratory tract diseasesmedicine.anatomical_structurePhenotype030228 respiratory systemPhysical therapyAge of onsetbusinessBiomarkersAnnals of the American Thoracic Society
researchProduct

Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?

2015

Inhalation is the preferred route of drug administration in chronic respiratory diseases because it optimises delivery of the active compounds to the targeted site and minimises side effects from systemic distribution. The choice of a device should be made after careful evaluation of the patient's clinical condition (degree of airway obstruction, comorbidities), as well as their ability to coordinate the inhalation manoeuvre and to generate sufficient inspiratory flow. These patient factors must be aligned with the specific advantages and limitations of each inhaler when making this important choice. Finally, adherence to treatment is not the responsibility of the patient alone, but should …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyChronic ObstructiveSocio-culturaleSettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Anti-asthmatic AgentMedication AdherencePulmonary DiseasePulmonary Disease Chronic ObstructiveSuspensionsAdministration InhalationmedicineCOPDHumansPharmacology (medical)Anti-Asthmatic AgentsMetered Dose InhalersRespiratory systemParticle SizeIntensive care medicineAsthmaAdherence; Asthma; COPD; Inhaler; Administration Inhalation; Anti-Asthmatic Agents; Dry Powder Inhalers; Humans; Medication Adherence; Metered Dose Inhalers; Particle Size; Pulmonary Disease Chronic Obstructive; Solutions; Suspensions; Nebulizers and Vaporizers; Pulmonary and Respiratory Medicine; Pharmacology (medical); Biochemistry (medical); Medicine (all)COPDInhalationbusiness.industryMedicine (all)InhalerNebulizers and VaporizersBiochemistry (medical)Adherence; Asthma; COPD; Inhaler; Administration Inhalation; Anti-Asthmatic Agents; Dry Powder Inhalers; Humans; Medication Adherence; Metered Dose Inhalers; Particle Size; Pulmonary Disease Chronic Obstructive; Solutions; Suspensions; Nebulizers and Vaporizers; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)InhalerDry Powder InhalersAirway obstructionmedicine.diseaseAsthmaSolutionsInhalationAdherenceAdministrationAdherence; Asthma; COPD; InhalerbusinessPulmonary pharmacologytherapeutics
researchProduct

Corrigendum to “Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?” [YPUPT 31C (2015) 63–67]

2015

NA

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryInhalerBiochemistry (medical)MedicinePharmacology (medical)asthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioRespiratory systembusinessIntensive care medicineAffect (psychology)Pulmonary Pharmacology & Therapeutics
researchProduct